As the phenotype of ENPP1 Deficiency evolves from GACI to ARHR2, a multidisciplinary team including geneticists, cardiologists, endocrinologists, and bone specialists is recommended to monitor cardiovascular involvement and the development of hypophosphatemic rickets, and to inform treatment decisions. The gene discussed is ENPP1; the disease is hypophosphatemic rickets.